Demand for pharmaceutical excipients in the US is projected to rise 4.3 percent per year to $2.0 billion in 2018. Gains will accelerate as excipients play a larger role in bringing additional value to pharmaceutical products by improving properties such as controlled release or better absorption of active ingredients. Polymers and gelatin will be the fastest growing types.This study analyzes the $1.6 billion US excipients industry. It presents historical demand data for 2003, 2008 and 2013, and forecasts for 2018 and 2023 by product (e.g., polymers, alcohols, minerals, gelatin, sugars) and application (e.g., fillers and diluents, binders, suspension and viscosity agents, coatings, solvents, flavoring agents, capsules, disintegrants, colorants, lubricants and glidants, preservatives).The study also considers market environment factors, details industry structure, evaluates company market share and profiles 47 industry players, including Dow Chemical, Ashland and FMC.
